Skip to main content
logo
BrightPath Biotherapeutics Co., Ltd. (TYO:4594)
Japan flag Japan · Delayed Price · Currency is JPY
50.00
-1.00 (-1.96%)
Aug 6, 2026, 1:07 PM JST

TYO:4594 Financials Overview

Millions JPY. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2018FY 2017
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '18 Mar '17
Revenue
0.080.081.130.07354529
Revenue Growth
-92.59%-92.59%1473.61%-99.98%-33.08%-
Gross Profit
0.060.061.10.05384
Operating Income
-1,295-1,295-1,161-1,155-1,562-1,114
Net Income
-1,305-1,305-1,151-1,168-1,577-1,113
Earnings Per Share
-11.70-11.70-14.12-18.21-41.25-32.72
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2018FY 2017
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '18 Mar '17
Cash & Investments
2,1562,156810.471,0576,5284,950
Total Debt
--25112.5--
Net Cash (Debt)
2,1562,156785.47944.866,5284,950
Net Cash Growth
174.51%174.51%-16.87%-85.53%31.88%-
Net Cash Per Share
19.3319.339.6414.73170.73145.52

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2018FY 2017
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '18 Mar '17
Operating Cash Flow
-1,366-1,366-1,250-1,157-1,591-1,067
Capital Expenditures
-0.59-0.59-1.37-6.19-108-97
Free Cash Flow
-1,366-1,366-1,252-1,163-1,699-1,164
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2018FY 2017
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '18 Mar '17
Gross Margin
65.48%65.48%97.18%75.00%10.73%0.76%
Operating Margin
-1541666.67%-1541666.67%-102464.08%-1604276.39%-441.24%-210.59%
Pretax Margin
-1550632.14%-1550632.14%-101434.16%-1619697.22%-444.35%-210.96%
Profit Margin
-1553513.09%-1553513.09%-101601.85%-1622336.11%-445.48%-210.40%
FCF Margin
-1626716.67%-1626716.67%-110479.17%-1615436.11%-479.94%-220.04%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2018FY 2017
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '18 Mar '17
PS Ratio
84326.81111001.553471.7063409.2795.1344.18